edaravone has been researched along with Meningitis, Pneumococcal in 1 studies
Meningitis, Pneumococcal: An acute purulent infection of the meninges and subarachnoid space caused by Streptococcus pneumoniae, most prevalent in children and adults over the age of 60. This illness may be associated with OTITIS MEDIA; MASTOIDITIS; SINUSITIS; RESPIRATORY TRACT INFECTIONS; sickle cell disease (ANEMIA, SICKLE CELL); skull fractures; and other disorders. Clinical manifestations include FEVER; HEADACHE; neck stiffness; and somnolence followed by SEIZURES; focal neurologic deficits (notably DEAFNESS); and COMA. (From Miller et al., Merritt's Textbook of Neurology, 9th ed, p111)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Z | 1 |
| Ma, QQ | 1 |
| Yan, Y | 1 |
| Xu, FD | 1 |
| Zhang, XY | 1 |
| Zhou, WQ | 1 |
| Feng, ZC | 1 |
1 other study available for edaravone and Meningitis, Pneumococcal
| Article | Year |
|---|---|
Edaravone attenuates hippocampal damage in an infant mouse model of pneumococcal meningitis by reducing HMGB1 and iNOS expression via the Nrf2/HO-1 pathway.
Topics: Animals; Antipyrine; Edaravone; HMGB1 Protein; Meningitis, Pneumococcal; Mice; Mice, Inbred C57BL; N | 2016 |